Testosterone transdermal - Viramal

Drug Profile

Testosterone transdermal - Viramal

Alternative Names: TestoCream

Latest Information Update: 25 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Viramal
  • Class Androstenols; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Hypogonadism

Highest Development Phases

  • Phase III Hypogonadism

Most Recent Events

  • 18 May 2016 Testosterone transdermal - Viramal is available for licensing in USA as of 18 May 2016. www.viramal.com
  • 18 May 2016 Phase-III clinical trials in Hypogonadism in USA before May 2016 (Topical)
  • 18 May 2016 Viramal has patent protection for drug delivery technology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top